PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI

被引:28
作者
de Rooij, Maarten [1 ]
Allen, Clare [2 ]
Twilt, Jasper J. [1 ]
Thijssen, Linda C. P. [1 ]
Asbach, Patrick [3 ,4 ,5 ,6 ]
Barrett, Tristan [7 ]
Brembilla, Giorgio [8 ]
Emberton, Mark [9 ,10 ]
Gupta, Rajan T. [11 ]
Haider, Masoom A. [12 ]
Kasivisvanathan, Veeru [9 ,10 ]
Logager, Vibeke [13 ]
Moore, Caroline M. [9 ,10 ]
Padhani, Anwar R. [11 ]
Panebianco, Valeria [12 ]
Puech, Philippe [13 ]
Purysko, Andrei S. [14 ,15 ,16 ]
Renard-Penna, Raphaele [17 ]
Richenberg, Jonathan [18 ]
Salomon, Georg [19 ]
Sanguedolce, Francesco [20 ,21 ]
Schoots, Ivo G. [22 ]
Thony, Harriet C. [22 ]
Turkbey, Baris [23 ]
Villeirs, Geert [24 ]
Walz, Jochen [25 ]
Barentsz, Jelle [26 ]
Giganti, Francesco [2 ,9 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Med Imaging, Nijmegen, Netherlands
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England
[3] Charite Univ Med Berlin, Dept Radiol, Berlin, Germany
[4] Free Univ Berlin, Berlin, Germany
[5] Humboldt Univ, Berlin, Germany
[6] Berlin Inst Hlth, Berlin, Germany
[7] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge, England
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy
[9] UCL, Div Surg & Intervent Sci, London, England
[10] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England
[11] Duke Univ Med Ctr, Dept Radiol, Durham, NC USA
[12] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Joint Dept Med Imaging, Sinai Hlth Syst, Toronto, ON, Canada
[13] Herlev Gentofte Univ Hosp, Dept Radiol, Herlev, Denmark
[14] Cleveland Clin, Diagnost Inst, Abdominal Imaging Sect, Cleveland, OH USA
[15] Cleveland Clin, Diagnost Inst, Nucl Radiol Dept, Cleveland, OH USA
[16] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA
[17] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Radiol, Paris, France
[18] Brighton & Sussex Univ Hosp NHS Trust, Dept Imaging, Brighton, E Sussex, England
[19] Univ Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany
[20] Univ Sassari, Dept Med Surg & Pharm, Sassari, Italy
[21] Fundacio Puigvert, Dept Urol, Barcelona, Spain
[22] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[23] NCI, NIH, Mol Imaging Branch, Bethesda, MD USA
[24] Ghent Univ Hosp, Dept Med Imaging, Ghent, Belgium
[25] Inst Paoli Calmettes Canc Ctr, Dept Urol, Marseille, France
[26] Andros Clin, Arnhem, Netherlands
关键词
Magnetic resonance imaging; Prostatic neoplasms; Quality control; CANCER; ACCURACY;
D O I
10.1007/s00330-024-10795-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI. We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.Clinical relevance statementHigh image quality is crucial for prostate MRI, and the updated version of the PI-QUAL score (PI-QUAL v2) aims to address the limitations of version 1. It is now applicable to both multiparametric MRI and MRI without intravenous contrast medium.Key PointsHigh-quality images are essential for prostate cancer diagnosis and management using MRI.PI-QUAL v2 simplifies image assessment and expands its applicability to prostate MRI without contrast medium.PI-QUAL v2 focuses on critical technical and qualitative image parameters and emphasises T2-WI and DWI.
引用
收藏
页码:7068 / 7079
页数:12
相关论文
共 34 条
  • [1] Regional Standardization of Prostate Multiparametric MRI Performance and Reporting: Is There a Role for a Director of Prostate Imaging?
    Abreu-Gomez, Jorge
    Shabana, Wael
    McInnes, Matthew D. F.
    O'Sullivan, Joseph P.
    Morash, Christopher
    Schieda, Nicola
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (04) : 844 - 850
  • [2] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
    Ahmed, Hashim U.
    Bosaily, Ahmed El-Shater
    Brown, Louise C.
    Gabe, Rhian
    Kaplan, Richard
    Parmar, Mahesh K.
    Collaco-Moraes, Yolanda
    Ward, Katie
    Hindley, Richard G.
    Freeman, Alex
    Kirkham, Alex P.
    Oldroyd, Robert
    Parker, Chris
    Emberton, Mark
    [J]. LANCET, 2017, 389 (10071) : 815 - 822
  • [3] Update on Optimization of Prostate MR Imaging Technique and Image Quality
    Barrett, Tristan
    Lee, Kang-Lung
    de Rooij, Maarten
    Giganti, Francesco
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (01) : 1 - 15
  • [4] Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway
    Barrett, Tristan
    de Rooij, Maarten
    Giganti, Francesco
    Allen, Clare
    Barentsz, Jelle O.
    Padhani, Anwar R.
    [J]. NATURE REVIEWS UROLOGY, 2023, 20 (01) : 9 - 22
  • [5] Deep Learning-Based Interpretable AI for Prostate T2W MRI Quality Evaluation
    Belue, Mason J.
    Law, Yan Mee
    Marko, Jamie
    Turkbey, Evrim
    Malayeri, Ashkan
    Yilmaz, Enis C.
    Lin, Yue
    Johnson, Latrice
    Merriman, Katie M.
    Lay, Nathan S.
    Wood, Bradford J.
    Pinto, Peter A.
    Choyke, Peter L.
    Harmon, Stephanie A.
    Turkbey, Baris
    [J]. ACADEMIC RADIOLOGY, 2024, 31 (04) : 1429 - 1437
  • [6] A multicentre assessment of prostate MRI quality and compliance with UK and international standards
    Burn, P. R.
    Freeman, S. J.
    Andreou, A.
    Burns-Cox, N.
    Persad, R.
    Barrett, T.
    [J]. CLINICAL RADIOLOGY, 2019, 74 (11) : 894.e19 - 894.e25
  • [7] Convolutional Neural Networks for Automated Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on Image Quality
    Cipollari, Stefano
    Guarrasi, Valerio
    Pecoraro, Martina
    Bicchetti, Marco
    Messina, Emanuele
    Farina, Lorenzo
    Paci, Paola
    Catalano, Carlo
    Panebianco, Valeria
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (02) : 480 - 490
  • [8] PI-QUAL v.1: the first step towards good-quality prostate MRI
    de Rooij, Maarten
    Barentsz, Jelle O.
    [J]. EUROPEAN RADIOLOGY, 2022, 32 (02) : 876 - 878
  • [9] ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training
    de Rooij, Maarten
    Israel, Bas
    Tummers, Marcia
    Ahmed, Hashim U.
    Barrett, Tristan
    Giganti, Francesco
    Hamm, Bernd
    Logager, Vibeke
    Padhani, Anwar
    Panebianco, Valeria
    Puech, Philippe
    Richenberg, Jonathan
    Rouviere, Olivier
    Salomon, Georg
    Schoots, Ivo
    Veltman, Jeroen
    Villeirs, Geert
    Walz, Jochen
    Barentsz, Jelle O.
    [J]. EUROPEAN RADIOLOGY, 2020, 30 (10) : 5404 - 5416
  • [10] Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis
    de Rooij, Maarten
    Hamoen, Esther H. J.
    Witjes, J. Alfred
    Barentsz, Jelle O.
    Rovers, Maroeska M.
    [J]. EUROPEAN UROLOGY, 2016, 70 (02) : 233 - 245